Home › Trial NCT05950594
IVIM & OLINK in Sarcoma
- Trial IDNCT05950594
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity Health Network, Toronto
- Enrollment145
- Start date2024-03-05
- ConditionsSoft Tissue Sarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.